Today, we’re diving into the latest healthcare and policy news, straight from D.C. Diagnosis, STAT’s newsletter. As we navigate through a tumultuous election season, it’s always nice to find some solace in shows like The Great British Baking Show. If you have any news tips or thoughts on Caramel Week, feel free to share them at [email protected].
Pharmaceutical executives have largely steered clear of political donations leading up to the election. However, those who have contributed have predominantly supported Democratic candidates, according to a recent STAT analysis of campaign finance filings. Check out the full story to see which executives have donated to Vice President Harris’ campaign, along with one outlier who supported Republicans.
The revolving door between the FDA and the tobacco industry is creating a complex landscape. As FDA regulators work to rein in the tobacco industry through lawsuits and regulations, they often find themselves facing former colleagues who now represent tobacco companies. This dynamic was highlighted in a recent partnership between STAT and The Examination, shedding light on the blurred lines between regulators and industry.
The GOP’s health plans are facing a shake-up with the rise of RFK Jr. and his alliance with former President Trump. RFK Jr.’s focus on chronic illnesses in children has sparked a broader conversation about public health reform within Trump’s circle. While some welcome this dialogue, others express concerns about Kennedy’s skepticism of science and its potential implications on public health.
In an unexpected twist, rent control and drug discounts collide in a California ballot measure. Michael Weinstein, an AIDS activist, has been pushing for rent control measures, prompting backlash from apartment builders. This clash has led to scrutiny of the 340B drug discount program, revealing an unlikely connection between housing policies and healthcare initiatives.
On the topic of addiction treatment, a recent survey by the Legal Action Center indicates strong bipartisan support for bolstering addiction treatment efforts. Despite its absence from the campaign trail, the survey shows that a majority of Americans, across party lines, believe that drug addiction should be treated as a medical issue rather than a criminal one. This shift in attitude reflects an increasing recognition of the importance of access to addiction treatment and support programs.
As we stay informed about the latest developments in healthcare and policy, here are some additional readings to dive into:
– Inside the challenges of the bird flu response, where profit motives clash with public health priorities
– Analysis of the controversial drug discount program, revealing significant revenue growth in the past year
– Discussion on redefining the role of the CDC in light of current public health challenges
– Exploration of the potential impact of the U.S. election on Medicare, drug pricing, and advancements in AI technology
Stay tuned for more updates on the evolving landscape of health and medicine, and don’t hesitate to share your thoughts and insights with us at [email protected].
